Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus

被引：0
|
作者：
Susan L. Campbell
Thomas van Groen
Inga Kadish
Lisa High Mitchell Smoot
Graeme B. Bolger
机构：
[1] University of Alabama at Birmingham,Department of Neurobiology
[2] University of Alabama at Birmingham,Department of Cell, Developmental and Integrative Biology
[3] University of Alabama at Birmingham,Department of Pharmacology
[4] University of Alabama at Birmingham,Department of Medicine
[5] Virginia Tech Carilion Research Institute,Center for Glial Biology in Health, Disease, and Cancer
来源：
BMC Neuroscience | / 18卷
关键词：
Learning; Memory; Depression; PKA; CREB; DISC1; PDE4; PDE4B1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR
    Mitchell, Charlotte J.
    Ballantine, Stuart P.
    Coe, Diane M.
    Cook, Caroline M.
    Delves, Christopher J.
    Dowle, Mike D.
    Edlin, Chris D.
    Hamblin, J. Nicole
    Holman, Stuart
    Johnson, Martin R.
    Jones, Paul S.
    Keeling, Sue E.
    Kranz, Michael
    Lindvall, Mika
    Lucas, Fiona S.
    Neu, Margarete
    Solanke, Yemisi E.
    Somers, Don O.
    Trivedi, Naimisha A.
    Wiseman, Joanne O.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5803 - 5806
  • [32] Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
    Kensei Komatsu
    Ji-Yun Lee
    Masanori Miyata
    Jae Hyang Lim
    Hirofumi Jono
    Tomoaki Koga
    Haidong Xu
    Chen Yan
    Hirofumi Kai
    Jian-Dong Li
    Nature Communications, 4
  • [33] Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
    Blauvelt, Andrew
    Langley, Richard G.
    Gordon, Kenneth B.
    Silverberg, Jonathan I.
    Eyerich, Kilian
    Sommer, Morten O. A.
    Felding, Jakob
    Warren, Richard B.
    DERMATOLOGY AND THERAPY, 2023, 13 (12) : 3031 - 3042
  • [34] Pde4b Influences Fibroblast Morphology, Proliferation, Matrix Production And Migration
    Choi, J.
    Ritzenthaler, J. D.
    Torres-Gonzalez, E.
    Gobejishvili, L.
    McClain, C.
    Barve, S.
    Roman, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [35] Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
    Komatsu, Kensei
    Lee, Ji-Yun
    Miyata, Masanori
    Lim, Jae Hyang
    Jono, Hirofumi
    Koga, Tomoaki
    Xu, Haidong
    Yan, Chen
    Kai, Hirofumi
    Li, Jian-Dong
    NATURE COMMUNICATIONS, 2013, 4
  • [36] Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme
    Siuciak, Judith A.
    McCarthy, Sheryl A.
    Chapin, Douglas S.
    Martin, Ashley N.
    PSYCHOPHARMACOLOGY, 2008, 197 (01) : 115 - 126
  • [37] Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)
    Han-Ting Zhang
    Ying Huang
    Anbrin Masood
    Lisa R Stolinski
    Yunfeng Li
    Lei Zhang
    Daniel Dlaboga
    S-L Catherine Jin
    Marco Conti
    James M O'Donnell
    Neuropsychopharmacology, 2008, 33 : 1611 - 1623
  • [38] PDE4B Proposed as a High Myopia Susceptibility Gene in Chinese Population
    Zhao, Fuxin
    Chen, Wei
    Zhou, Hui
    Reinach, Peter S.
    Wang, Yuhan
    Juo, Suh-Hang H.
    Yang, Zhenglin
    Xue, Anquan
    Shi, Yi
    Liang, Chung-Ling
    Zeng, Changqing
    Qu, Jia
    Zhou, Xiangtian
    FRONTIERS IN GENETICS, 2022, 12
  • [39] Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
    Andrew Blauvelt
    Richard G. Langley
    Kenneth B. Gordon
    Jonathan I. Silverberg
    Kilian Eyerich
    Morten O. A. Sommer
    Jakob Felding
    Richard B. Warren
    Dermatology and Therapy, 2023, 13 : 3031 - 3042
  • [40] Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B
    Manning, CD
    Burman, M
    Christensen, SB
    Cieslinski, LB
    Essayan, DM
    Grous, M
    Torphy, TJ
    Barnette, MS
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (07) : 1393 - 1398
12345